-
Jan 6, 2025 | 
jdsupra.com | Anna K. Abram |Kevin Brady |Sean Feely
January 6, 2025 Anna Abram, Shawn Maree Bishop, Kevin Brady, Sean Feely, Kandis McClure, Samuel Olswanger, Jocelyn Wiles Akin Gump Strauss Hauer & Feld LLP + Follow x Following x Following - Unfollow Contact To embed, copy and paste the code into your website or blog: As the new year begins, change is afoot inside the Beltway as the 119th Congress gets underway and Washington prepares for President Trump’s second administration. While change is bringing uncertainty on some fronts, health care...
-
Oct 17, 2024 | 
mondaq.com | Anna K. Abram |Craig B. Bleifer |Sean Feely |Kandis McClure
Recent drug pricing developments underscore that the focus on
drug pricing issues is likely to continue regardless of the outcome
of the upcoming November elections.
CMS recently released final guidance on the Medicare Drug Price
Negotiation Program and issued a Request for Information on a
proposed Medicare $2 Drug List Model for comment.
-
Oct 16, 2024 | 
jdsupra.com | Anna K. Abram |Craig B. Bleifer |Sean Feely
Recent drug pricing developments underscore that the focus on drug pricing issues is likely to continue regardless of the outcome of the upcoming November elections. CMS recently released final guidance on the Medicare Drug Price Negotiation Program and issued a Request for Information on a proposed Medicare $2 Drug List Model for comment.
-
Oct 16, 2024 | 
akingump.com | Anna K. Abram |Craig B. Bleifer |Sean Feely |Kandis McClure
Recent drug pricing developments underscore that the focus on drug pricing issues is likely to continue regardless of the outcome of the upcoming November elections. CMS recently released final guidance on the Medicare Drug Price Negotiation Program and issued a Request for Information on a proposed Medicare $2 Drug List Model for comment.
-
Oct 16, 2024 | 
lexology.com | Anna K. Abram |Craig B. Bleifer |Sean Feely |Kandis McClure
Recent drug pricing developments underscore that the focus on drug pricing issues is likely to continue regardless of the outcome of the upcoming November elections. CMS recently released final guidance on the Medicare Drug Price Negotiation Program and issued a Request for Information on a proposed Medicare $2 Drug List Model for comment.
-
Aug 15, 2024 | 
mondaq.com | Anna K. Abram |Craig B. Bleifer |Sean Feely |Kandis McClure
This week marks the second anniversary of the enactment of the
Inflation Reduction Act, a partisan law that ushered in sweeping
Medicare price setting reforms.
The Biden-Harris Administration is poised to announce the first
round of final "negotiated" drug prices, a defining
milestone in IRA implementation.
As IRA implementation moves forward, Constitutional challenges
to the law continue to be litigated in the courts.
-
Aug 14, 2024 | 
jdsupra.com | Anna K. Abram |Craig B. Bleifer |Sean Feely
[co-author: Kandis McClure (Policy Advisor)] This week marks the second anniversary of the enactment of the Inflation Reduction Act, a partisan law that ushered in sweeping Medicare price setting reforms. The Biden-Harris Administration is poised to announce the first round of final “negotiated” drug prices, a defining milestone in IRA implementation. As IRA implementation moves forward, Constitutional challenges to the law continue to be litigated in the courts.
-
Aug 14, 2024 | 
akingump.com | Anna K. Abram |Craig B. Bleifer |Sean Feely
This week marks the second anniversary of the enactment of the Inflation Reduction Act, a partisan law that ushered in sweeping Medicare price setting reforms. The Biden-Harris Administration is poised to announce the first round of final “negotiated” drug prices, a defining milestone in IRA implementation. As IRA implementation moves forward, Constitutional challenges to the law continue to be litigated in the courts.
-
Sep 6, 2023 | 
ajp.com.au | Megan Haggan |Laverne Baulch |Sean Feely |Nicholas O’Donoghue
House of Reps speaker calls alleged pharmacist behaviour “unacceptable,” as the health minister criticises the Coalition over the incident Milton Dick, speaker of the House of Representatives, issued a warning statement regarding the behaviour of visitors to the public gallery on Tuesday (6 September 2023), following an incident there the previous day. Around 2,500 pharmacistsThis content is restricted to registered users only.
-
Sep 5, 2023 | 
lexology.com | G. Hunter Bates |Brian Arthur Pomper |Anna Marie Abram |Sean D'Arcy |Brendan Dunn |John Gilliland | +11 more
IntroductionCongress returns from the August recess with a robust agenda and limited time to pursue it. The calendar is further constrained by the September 30 deadline to pass appropriations packages or a continuing resolution (CR) to avoid a shutdown of the federal government.
